However, one potential side effect that requires monitoring is an elevated hematocrit level
The findings identified a mechanism distinct from previously known appetite-control pathways as an avenue by which GLP-1s could treat other dysfunctions in reward processing, such as substance use disorder
Benefits of Semaglutide Weight Loss Injections Guerda Johnson, FNP-C helps LongviewMarshallTyler patients achieve optimal health by delivering superior care through innovative medicine
Pasireotide long-acting release (PAS-LAR) has also been reported to lower serum GLP-1 and GIP levels in phase 1 studies conducted on healthy volunteers 21
[DOI] [PMC free article] [PubMed] [Google Scholar] Pawlak 2013 Pawlak R, Parrott SJ, Raj S, CullumDugan D, Lucus D
10.1128/MMBR.66.2.250-271.2002 Microbiol